Market Cap 331.52M
Revenue (ttm) 213.65M
Net Income (ttm) -38.80M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -18.16%
Debt to Equity Ratio 0.00
Volume 125,500
Avg Vol 83,394
Day's Range N/A - N/A
Shares Out 20.97M
Stochastic %K 68%
Beta 0.82
Analysts Hold
Price Target $12.50

Company Profile

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 353 0 166 99020
Address:
One Central Plaza, 8th Floor 36 Dame Street, Dublin, Ireland
CaptBeer
CaptBeer Jun. 25 at 12:25 AM
$AMRN Here's how Today ended:
1 · Reply
Family23
Family23 Jun. 24 at 8:41 PM
$AMRN SDL are you out there?!?! I’m ready to cash in my chips, buyout still right around the corner?
0 · Reply
DoMoreCharity
DoMoreCharity Jun. 24 at 8:32 PM
$AMRN Pharmaceutical Omega-3 API Market to Reach USD 2.3 Billion by 2036 as Prescription Cardiovascular Therapies Drive Demand for High-Purity EPA APIs, FMI https://www.24-7pressrelease.com/press-release/536140/pharmaceutical-omega-3-api-market-to-reach-usd-23-billion-by-2036-as-prescription-cardiovascular-therapies-drive-demand-for-high-purity-epa-apis-fmi
0 · Reply
TraderRapp
TraderRapp Jun. 24 at 8:20 PM
$AMRN if this dares to rechallmege that $17.20 again, it will be unusual for Amrn price action
0 · Reply
SanDiegoLiving
SanDiegoLiving Jun. 24 at 8:12 PM
$AMRN 🔥 THE QUIET CLEANUP IS OVER — THE REINTRODUCTION CAMPAIGN HAS STARTED 🔥 1 year ago today (6/24/25), Recordati took over Europe, the move tied to Amarin’s ~$70M OpEx reset. That reset officially completes by June 30. A recent IR switch also fits the timing. Around Feb, Amarin’s investor contact shifted to The Equity Group: 📌 Devin Sullivan 📌 Conor Rodriguez Their lane isn’t passive PR: 🎯 buy-side + sell-side targeting 🎯 investor/analyst outreach 🎯 conference planning 🎯 messaging refinement 🎯 transactional IR Now layer in JPM buy-side/sell-side “get current” activity + Goldman Sachs healthcare conference visibility. ✅ Europe outsourced ✅ Costs reset ✅ IR upgraded ✅ Institutions re-engaged The cleanup clock is hitting zero & Amarin looks like it’s being reintroduced to the market with a cleaner story/sharper audience. So the real question: was Barclays hired to explore options, or to help reintroduce a cleaned-up asset to the right audience? 👀⏳
1 · Reply
Shark2025
Shark2025 Jun. 24 at 7:58 PM
$AMRN Will it hold up…..
0 · Reply
PghKid1
PghKid1 Jun. 24 at 7:50 PM
$AMRN I added to this POS last week. As much as I hate it, I don’t want to miss out after 14 years!
0 · Reply
declanaidan
declanaidan Jun. 24 at 7:47 PM
$AMRN Volume precedes price..In.last couple weeks seeing significant increase in relative volume, and pps increase slowly following
0 · Reply
Patrick2343
Patrick2343 Jun. 24 at 7:21 PM
$AMRN think new formulation
0 · Reply
ians
ians Jun. 24 at 7:01 PM
$AMRN BULL case valuation of $50.51🤑 Any sign of a BP sniffing around, & we should reach that optimistic upper range 👍 C'mon MRK, NVS, NOVO ☘️💎 https://stocktwits.com/ians/message/648011821
1 · Reply
Latest News on AMRN
Amarin Reports 2026 First Quarter Financial Results

Apr 29, 2026, 7:00 AM EDT - 2 months ago

Amarin Reports 2026 First Quarter Financial Results


Amarin highlights new recommendation for treatment of CV risk

2026-03-18T12:41:54.000Z - 3 months ago

Amarin highlights new recommendation for treatment of CV risk


Amarin highlights recent data published on REDUCE-IT study

2026-03-02T13:26:30.000Z - 4 months ago

Amarin highlights recent data published on REDUCE-IT study


Amarin issues call to action for American Heart Month

2026-02-23T13:23:34.000Z - 4 months ago

Amarin issues call to action for American Heart Month


Amarin expects Q4 net revenue $48M-$43M

2026-01-08T12:06:26.000Z - 5 months ago

Amarin expects Q4 net revenue $48M-$43M


Amarin reports Q3 EPS (2c) vs (6c) last year

2025-10-29T11:11:18.000Z - 8 months ago

Amarin reports Q3 EPS (2c) vs (6c) last year


Amarin presents new REDUCE-IT analyses

2025-09-01T12:30:11.000Z - 10 months ago

Amarin presents new REDUCE-IT analyses


Amarin announces upcoming presentations at ESC Congress 2025

2025-08-25T12:05:06.000Z - 10 months ago

Amarin announces upcoming presentations at ESC Congress 2025


Amarin expects accelerated in-market demand in Europe

2025-07-30T11:11:52.000Z - 11 months ago

Amarin expects accelerated in-market demand in Europe


Amarin Reports Second Quarter 2025 Financial Results

Jul 30, 2025, 7:00 AM EDT - 11 months ago

Amarin Reports Second Quarter 2025 Financial Results


Amarin regains compliance with Nasdaq

2025-04-29T20:40:18.000Z - 1 year ago

Amarin regains compliance with Nasdaq


Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change

Apr 9, 2025, 7:30 AM EDT - 1 year ago

Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change


Amarin Receives National Reimbursement for VAZKEPA® in Italy

Dec 16, 2024, 7:00 AM EST - 1 year ago

Amarin Receives National Reimbursement for VAZKEPA® in Italy


Amarin Appoints Peter Fishman Chief Financial Officer

Dec 13, 2024, 9:00 AM EST - 1 year ago

Amarin Appoints Peter Fishman Chief Financial Officer


Amarin Board of Directors Announces CEO Transition

Jun 4, 2024, 7:30 AM EDT - 2 years ago

Amarin Board of Directors Announces CEO Transition


Amarin Chairman & CEO Issue Letter to Shareholders

Jan 22, 2024, 7:30 AM EST - 2 years ago

Amarin Chairman & CEO Issue Letter to Shareholders


CaptBeer
CaptBeer Jun. 25 at 12:25 AM
$AMRN Here's how Today ended:
1 · Reply
Family23
Family23 Jun. 24 at 8:41 PM
$AMRN SDL are you out there?!?! I’m ready to cash in my chips, buyout still right around the corner?
0 · Reply
DoMoreCharity
DoMoreCharity Jun. 24 at 8:32 PM
$AMRN Pharmaceutical Omega-3 API Market to Reach USD 2.3 Billion by 2036 as Prescription Cardiovascular Therapies Drive Demand for High-Purity EPA APIs, FMI https://www.24-7pressrelease.com/press-release/536140/pharmaceutical-omega-3-api-market-to-reach-usd-23-billion-by-2036-as-prescription-cardiovascular-therapies-drive-demand-for-high-purity-epa-apis-fmi
0 · Reply
TraderRapp
TraderRapp Jun. 24 at 8:20 PM
$AMRN if this dares to rechallmege that $17.20 again, it will be unusual for Amrn price action
0 · Reply
SanDiegoLiving
SanDiegoLiving Jun. 24 at 8:12 PM
$AMRN 🔥 THE QUIET CLEANUP IS OVER — THE REINTRODUCTION CAMPAIGN HAS STARTED 🔥 1 year ago today (6/24/25), Recordati took over Europe, the move tied to Amarin’s ~$70M OpEx reset. That reset officially completes by June 30. A recent IR switch also fits the timing. Around Feb, Amarin’s investor contact shifted to The Equity Group: 📌 Devin Sullivan 📌 Conor Rodriguez Their lane isn’t passive PR: 🎯 buy-side + sell-side targeting 🎯 investor/analyst outreach 🎯 conference planning 🎯 messaging refinement 🎯 transactional IR Now layer in JPM buy-side/sell-side “get current” activity + Goldman Sachs healthcare conference visibility. ✅ Europe outsourced ✅ Costs reset ✅ IR upgraded ✅ Institutions re-engaged The cleanup clock is hitting zero & Amarin looks like it’s being reintroduced to the market with a cleaner story/sharper audience. So the real question: was Barclays hired to explore options, or to help reintroduce a cleaned-up asset to the right audience? 👀⏳
1 · Reply
Shark2025
Shark2025 Jun. 24 at 7:58 PM
$AMRN Will it hold up…..
0 · Reply
PghKid1
PghKid1 Jun. 24 at 7:50 PM
$AMRN I added to this POS last week. As much as I hate it, I don’t want to miss out after 14 years!
0 · Reply
declanaidan
declanaidan Jun. 24 at 7:47 PM
$AMRN Volume precedes price..In.last couple weeks seeing significant increase in relative volume, and pps increase slowly following
0 · Reply
Patrick2343
Patrick2343 Jun. 24 at 7:21 PM
$AMRN think new formulation
0 · Reply
ians
ians Jun. 24 at 7:01 PM
$AMRN BULL case valuation of $50.51🤑 Any sign of a BP sniffing around, & we should reach that optimistic upper range 👍 C'mon MRK, NVS, NOVO ☘️💎 https://stocktwits.com/ians/message/648011821
1 · Reply
Noelan09
Noelan09 Jun. 24 at 6:59 PM
0 · Reply
thisguysfalling
thisguysfalling Jun. 24 at 6:57 PM
$AMRN It would be nice if we could hold today’s gains into the close.🤞
1 · Reply
Novo1
Novo1 Jun. 24 at 3:57 PM
$AMRN shortage of over-the-counter Omega-3 fish oil??🥴🥴
1 · Reply
CaptBeer
CaptBeer Jun. 24 at 12:41 PM
$AMRN Another look at the OHLCV chart for May & June (so far). Let's see what today does.
0 · Reply
NilsSB
NilsSB Jun. 24 at 1:34 AM
0 · Reply
NilsSB
NilsSB Jun. 24 at 1:32 AM
0 · Reply
buygreensellredchop
buygreensellredchop Jun. 23 at 10:44 PM
$AMRN Everyone getting excited on a small bump in share price.. pathetic. Wake me up when share price is respectful.. this is garbage..
2 · Reply
DoMoreCharity
DoMoreCharity Jun. 23 at 10:43 PM
$AMRN https://www.linkedin.com/posts/amelia-carro-hevia-90534468_icosapent-ethtyl-cardiac-metabolomic-lipidomic-ugcPost-7467106508346937346-f29h?utm_source=share&utm_medium=member_ios&rcm=ACoAAAappXEBEo5xWglK2bmEx478x0aaRWW4o7I
0 · Reply
tsingyuanTemp
tsingyuanTemp Jun. 23 at 4:10 PM
$AMRN can we see amrn more than 20 in year 2026?
1 · Reply
NilsSB
NilsSB Jun. 23 at 3:00 PM
$AMRN this bi-polar ass stock. Might as well rename this company after my ex.
1 · Reply
revivedfossil
revivedfossil Jun. 23 at 1:31 PM
$AMRN crazy premarket shenanigans on 70 shares
0 · Reply
CaptBeer
CaptBeer Jun. 23 at 1:15 PM
$AMRN VAZKEPA is not only capturing the OMG-3 Market Share, but that Market is growing. The Market is set for 1,000,000 Caps/Month very soon!
3 · Reply